Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib

被引:0
|
作者
Tore K Kvien
Maria Greenwald
Paul M Peloso
Hongwei Wang
Anish Mehta
Arnold Gammaitoni
机构
[1] Diakonhjemmet Hospital,Department of Rheumatology
[2] Desert Medical Advances,Clinical Research
[3] Merck & Co.,undefined
[4] Inc.,undefined
来源
BMC Musculoskeletal Disorders | / 16卷
关键词
bDMARDS; Rheumatoid arthritis; Analgesics; Corticosteroids; Pain; COX-2 inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 3 条
  • [1] Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib
    Kvien, Tore K.
    Greenwald, Maria
    Peloso, Paul M.
    Wang, Hongwei
    Mehta, Anish
    Gammaitoni, Arnold
    BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [2] CHARACTERISTICS OF PATIENTS WHO RESPOND POORLY TO REDUCTION OF BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS; RT-4 STUDY POST HOC ANALYSIS
    Urata, Y.
    Abe, S.
    Devers, B.
    Nakamura, Y.
    Takemoto, H.
    Furukawa, K. -I.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 800 - 800
  • [3] The effects of sarilumab as monotherapy and in combination with non-methotrexate disease-modifying anti-rheumatic drugs on unacceptable pain in patients with rheumatoid arthritis: A post-hoc analysis of the HARUKA phase 3 study
    Tanaka, Yoshiya
    Takahashi, Toshiya
    van Hoogstraten, Hubert
    Kato, Naoto
    Kameda, Hideto
    MODERN RHEUMATOLOGY, 2024,